FDA recall, , Moderate risk
Department of Defense Air Force Red Blood Cells
Red Blood Cells were collected from a donor who previously tested repeatedly reactive for HTLV-I antibody.
Recall ended Sep 21, 2026. Still check yours.
Summary by Recall Canary from the FDA notice
What happened
The Department of Defense - Air Force recalled one unit of Red Blood Cells because the product was collected from a donor who previously tested repeatedly reactive for the antibody to Human T-Lymphotropic Virus (HTLV-I). The recall began on April 22, 2025, and the FDA added it to its Enforcement Report on September 21, 2026, the same day it was classified. The product was distributed in New Jersey.
What to do
We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:
- Check the FDA or company notice for instructions specific to this product.
- Ask your pharmacist or doctor whether your lot is affected and what to do.
Is yours affected?
Compare these details with yours, then check the recall notice to see which units are recalled.
Red Blood Cells
Recall details
- Company began the recall
- Sold in
- Company
- Department of Defense - Air Force
- Hazard
- Blood donor screening
- Risk
Moderate risk
Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- Event ID
- 98865
- Recall number
- B-0201-2026
- Quantity recalled
- 1 unit
Timeline
FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.
Company began the recall
Added to FDA's Enforcement Report · Classified by FDA · Recall ended
In FDA's weekly enforcement report
Listed on Recall Canary
